Skip to main content

Advertisement

Table 2 Analysis of the correlation between CTCs counts with NSCLC clinical stage

From: Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo

Stage No. of cases (n) CTC count (mean ± SD) 95% CI rs P-value
I 26 49.46 ± 13.34 26.04–80.81 − 0.25 0.015
II 17 23.53 ± 13.32 5.28–52.53
III 16 29.88 ± 13.66 6.29–58.37
IV 30 14.63 ± 4.38 8.42–23.50
  1. CTC circulating tumor cells